DSIP vs Melatonin

DSIP

A 9-amino-acid peptide originally isolated from rabbit brain on the hypothesis that it triggers delta-wave sleep. The real-world signal in humans is mixed and the trial base is small and old.

Best for

Best only if you want to experiment with deep-sleep architecture and accept the thin human evidence.

Melatonin

The body's own sleep-onset hormone, sold as an over-the-counter supplement in most jurisdictions. Effective and cheap when used correctly — and chronically overdosed by almost everyone who uses it.

Best for

Best for most people — cheap, safe, well-studied, and effective at shifting sleep timing.

DSIP

Small human trials in the 1980s explored DSIP in chronic insomnia, alcohol withdrawal, and chronic pain, with mixed results from Schoenenberger's group and others. No modern RCTs exist in the Western literature. The pharmacology has never fully fit the original delta-sleep hypothesis. Treat the sleep-depth effect as a real but inconsistent user-level observation rather than a proven clinical finding.

Melatonin

Approved as a prescription drug (Circadin and others) in the EU for short-term insomnia in adults over 55, and sold OTC as a supplement in most of the world. The Cochrane reviews support short-term use for sleep onset, jet lag, and delayed sleep phase disorder. The trial base for high-dose long-term use is thinner than the marketing suggests — most positive trials use 0.5–3 mg. Cite Auld 2017 and the 2017 BMJ jet-lag review as anchors.